INVAMED, INC.

INVAMED is a Turkish medical device manufacturer headquartered in Ankara, founded in 2005, with operations spanning 15,000 m² and over 200 specialist employees. The company manufactures over 150 CE-marked medical devices across 23 product categories, exported to more than 80 countries with over 100 international patents. INVAMED specializes in cardiovascular and neurovascular interventional devices including coronary stents (ATLAS drug-eluting platform), mechanical thrombectomy systems (Mantis platform), and embolization devices (MultiBEAM vascular plugs, Spider coils, LIBRO EVOH liquid embolic agent). The company also produces comprehensive orthopedic implant solutions (CytroFIX system with intramedullary nails and locking plates), varicose vein treatment systems (VenaBLOCK, ThermoBLOCK, LaserBLOCK), aortic stent grafts (STENA MFM), and specialty devices for urology, ENT, pain management, dental implants (DENTURA), and digital health monitoring (RhythmTrack cardiac telemetry). All products comply with EU MDR 2017/745 and ISO 13485 standards. INVAMED maintains an in-house R&D center (INVAcenter) with 40+ biomedical engineers and has delivered over 500,000 device units since 2010.